In the first three years, the KSU-LKSKI collaborative partnership has attained incredible success resulting in a more than 130 research projects, including:
- 1 US Patent
- 19 publications in peer-reviewed medical journals
- 12 articles submitted for peer review
- 28 manuscripts in preparation
- 67 abstracts
- 7 symposium / conferences sponsored
- 39 experiential research training visits by KSU faculty, residents, students, and technical staff
- 3 awards for research excellence
Of note, the KSU-LKSKI collaborative research efforts and KSUProgram alumni efforts has resulted in a United Stated Patent Application Publication (Verma S, Al-Omran M. Methods for Preventing and Treating Cardiovascular Diseases with BRCA1.) as well as publications in prestigious international peer-reviewed journals such as:
- Nature Communications (Shukla PC, Singh KK, Quan A, Al-Omran M, Teoh H, Lovren F, Cao L, Rovira II, Pan Y, Brezden-Masley C, Yanagawa B, Gupta A, Deng C-X, Coles JG, Leong-Poi H, Stanford WL, Parker TG, Schneider MD, Finkel T, Verma S. BRCA1 is an Essential Regulator of Heart Function and Survival following Myocardial Infarction.)
- The Journal of Biological Chemistry (Singh K, Shukla PC, Quan A, Desjardins JF, Lovren F, Pan Y, Garg V, Gosal1 S, Garg A, Szmitko PE, Schneider MD, Parker TG, Stanford WL, Leong-Poi H, Teoh H, Al-Omran M, Verma S. BRCA2 Deficiency Exaggerates Doxorubicin-Induced Cardiomyocyte Apoptosis and Cardiac Failure.)
- The Journal of Vascular Surgery (Altoijry A, Mamdani M, Al-Omran M. Trends in Abdominal Aortic Aneurysm Repair in the Era of Endovascular Technology in Ontario.)
- The New England Journal of Medicine (Aljabri B, Al-Omran M. Medical Image: Giant Abdominal Aortic Aneurysm.)
- Proceedings of the National Academy of Sciences (De Nigris F, Crudele V, Cito L, Hayashi T, Al-Omran M, Ignarro L, Napoli C. CXCR4/YY1 inhibition impairs VEGF network and angiogenesis during malignancy.)